Skip to content
← Catalog

Pregene · Kite/Gilead deal $1.64B

Pregene · 中国 in vivo / cell therapy 公司 · 与 Kite (Gilead) 达成 $1.64B deal(per OPORD-002 §2 P1 verify list)。对 SunVax 的对标:in vivo 方向 · 地理上中国市场参考 anchor · 具体 deal terms (upfront + milestones) 待 verify。

Type
company
Domain
conference
Grade
conference
License
LIGHT_HOPE_proprietary
evidence_grade
B
category
in_vivo_car_t_lentiviral
status
draft
instance_tag
sunvax-antibody-2025
acquisitions
[object Object]

Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.